Academic literature on the topic 'COX-2 selective inhibitor'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'COX-2 selective inhibitor.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "COX-2 selective inhibitor"
NAKAMURA, Hideo. "Cyclooxygenase (COX)-2 selective inhibitors: aspirin, a dual COX-1/COX-2 inhibitor, to COX-2 selective inhibitors." Folia Pharmacologica Japonica 118, no. 3 (2001): 219–30. http://dx.doi.org/10.1254/fpj.118.219.
Full textEibl, Guido, Yasunori Takata, Laszlo G. Boros, et al. "Growth Stimulation of COX-2–Negative Pancreatic Cancer by a Selective COX-2 Inhibitor." Cancer Research 65, no. 3 (2005): 982–90. http://dx.doi.org/10.1158/0008-5472.982.65.3.
Full text&NA;. "Rofecoxib: a selective COX-2 inhibitor." Drugs & Therapy Perspectives 15, no. 2 (2000): 1–5. http://dx.doi.org/10.2165/00042310-200015020-00001.
Full textMartina, Shaunta‘ D., Kimi S. Vesta, and Toni L. Ripley. "Etoricoxib: A Highly Selective COX-2 Inhibitor." Annals of Pharmacotherapy 39, no. 5 (2005): 854–62. http://dx.doi.org/10.1345/aph.1e543.
Full textDegraeve, Frédéric, Manlio Bolla, Stéphanie Blaie, et al. "Modulation of COX-2 Expression by Statins in Human Aortic Smooth Muscle Cells." Journal of Biological Chemistry 276, no. 50 (2001): 46849–55. http://dx.doi.org/10.1074/jbc.m104197200.
Full textJeger, Raban V., Jeffrey D. Greenberg, Krishnan Ramanathan, and Michael E. Farkouh. "Lumiracoxib, a highly selective COX-2 inhibitor." Expert Review of Clinical Immunology 1, no. 1 (2005): 37–45. http://dx.doi.org/10.1586/1744666x.1.1.37.
Full text&NA;. "Rofecoxib: a selective and effective COX-2 inhibitor." Drugs & Therapy Perspectives 18, no. 2 (2002): 1–3. http://dx.doi.org/10.2165/00042310-200218020-00001.
Full textMiller, Jane L. "Second selective COX-2 inhibitor receives marketing approval." American Journal of Health-System Pharmacy 56, no. 13 (1999): 1294. http://dx.doi.org/10.1093/ajhp/56.13.1294a.
Full textTakahashi, Toshiyuki, and Mitsuo Miyazawa. "N-Caffeoyl serotonin as selective COX-2 inhibitor." Bioorganic & Medicinal Chemistry Letters 22, no. 7 (2012): 2494–96. http://dx.doi.org/10.1016/j.bmcl.2012.02.002.
Full textZhu, Xi-Tian, Lei Chen, and Jian-Hua Lin. "Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty." Medicine 97, no. 31 (2018): e11649. http://dx.doi.org/10.1097/md.0000000000011649.
Full textDissertations / Theses on the topic "COX-2 selective inhibitor"
Davies, Richard. "Effect of selective COX-2 inhibitors on hepatic progenitor cells and the pathologies of experimental hepatocarcinogenesis." University of Western Australia. School of Medicine and Pharmacology, 2007. http://theses.library.uwa.edu.au/adt-WU2007.0190.
Full textLi, Zhigang. "Suppression of N-nitrosomethylbenzylamine(NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522,a selective COX-2 inhibitor." Kyoto University, 2002. http://hdl.handle.net/2433/149320.
Full textSilva, Aline Alves da. "Avaliação clínica de Rattus norvegicus após terapia antiinflamatória com inibidor seletivo ou não para COX-2 por extrapolação alométrica." Universidade Federal de Santa Maria, 2004. http://repositorio.ufsm.br/handle/1/4112.
Full textKing, Liam Denson. "COX-2 selective inhibitors as an adjunct to radiotherapy." Thesis, Griffith University, 2018. http://hdl.handle.net/10072/382714.
Full textHasan, Kamrul. "Clclo-oxygenase (COX) isoforms in the cardiovascular system : Implications for the future of COX-2 selective inhibitors." Thesis, Imperial College London, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.536024.
Full textChen, Qilei. "Discovery of COX-2 selective inhibitors from saussurea laniceps using an enzyme-anchored nanomagnetic ligand fishing platform." HKBU Institutional Repository, 2020. https://repository.hkbu.edu.hk/etd_oa/708.
Full textGu, Baoying. "Selective increase of neuronal cyclooxygenase-2 (COX-2) expression in vulnerable brain regions of rats with experimental Wernicke's encephalopathy : effects of nimesulide." Thesis, McGill University, 2007. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=112627.
Full textSawdy, Robert John. "The role of the type-2 isoform of the cyclooxygenase enzyme (COX-2) in human parturition : potential benefits of selective COX-2 inhibitors in the management of preterm labour." Thesis, Imperial College London, 2003. http://hdl.handle.net/10044/1/11444.
Full textBorges, Alexandre [UNESP]. "Estudos de modelagem molecular de lignanas em complexos com ciclooxigenases-1 e 2." Universidade Estadual Paulista (UNESP), 2016. http://hdl.handle.net/11449/140137.
Full textBorges, Alexandre. "Estudos de modelagem molecular de lignanas em complexos com ciclooxigenases-1 e 2 /." Ilha Solteira, 2016. http://hdl.handle.net/11449/140137.
Full textBooks on the topic "COX-2 selective inhibitor"
Vane, John, and Jack Botting, eds. Selective COX-2 Inhibitors. Springer Netherlands, 1998. http://dx.doi.org/10.1007/978-94-011-4872-6.
Full textR, Vane John, Botting Jack H, and William Harvey Research Conference (1997 : Cannes, France), eds. Selective COX-2 inhibitors: Pharmacology, clinical effects and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France. Kluwer Academic, 1998.
Find full textR, Vane John, Botting Regina M, William Harvey Research Conference (1997 : Phuket, Thailand), and William Harvey Research Conference (1998 : Boston, Mass.), eds. Clinical significance and potential of selective COX-2 inhibitors: The combined proceedings of the William Harvey Conferences held in Phuket, Thailand, on 18-19 September, 1997 and in Boston, USA, on 23-24 April, 1998, supported by an educational grant from Boehringer Ingelheim. William Harvey Press, 1998.
Find full textSimon, Lee S., and Marc C. Hochberg. Non-steroidal anti-inflammatory drugs. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199668847.003.0030.
Full textVane, Sir John, ed. Clinical Significance And Potential Of Selective Cox-2 Inhibitors. WILLIAM HARVEY PRESS, 1998.
Find full textSir John R. Vane (Editor) and Jack H. Botting (Editor), eds. Selective COX-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential. Springer, 1998.
Find full textBotting, Jack H., and Sir John R. Vane. Selective COX-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential. Springer, 2012.
Find full textSelective COX-2 inhibitors: Pharmacology, clinical effects, and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France. Kluwer Academic, 1998.
Find full textBook chapters on the topic "COX-2 selective inhibitor"
Lau, C. K., W. C. Black, M. Belley, et al. "From Indomethacin to a Selective Cox-2 Inhibitor." In Advances in Experimental Medicine and Biology. Springer US, 1997. http://dx.doi.org/10.1007/978-1-4899-1813-0_11.
Full textBolten, W. "Clinical experience with meloxicam, a selective COX-2 inhibitor." In New Targets in Inflammation. Springer Netherlands, 1996. http://dx.doi.org/10.1007/978-94-011-5386-7_12.
Full textAkarsu, Eyup S., Soner Mamuk, and Sibel Arat. "Variable Antipyretic Effect of SC-58236, a Selective Cyclooxygenase (COX)-2 Inhibitor, in Rats." In Advances in Experimental Medicine and Biology. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4419-9194-2_28.
Full textKalgutkar, Amit S., Brenda C. Crews, Scott W. Rowlinson, Carlos Garner, and Lawrence J. Marnett. "Discovery of a New Class of Selective Cyclooxygenase-2 (COX-2) Inhibitor that Covalently Modifies the Isozyme." In Advances in Experimental Medicine and Biology. Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-4793-8_21.
Full textVane, J. R., and R. M. Botting. "Mechanism of action of anti-inflammatory drugs: an overview." In Selective COX-2 Inhibitors. Springer Netherlands, 1998. http://dx.doi.org/10.1007/978-94-011-4872-6_1.
Full textGryglewski, R. J. "Aspirin-induced asthma and cyclooxygenases." In Selective COX-2 Inhibitors. Springer Netherlands, 1998. http://dx.doi.org/10.1007/978-94-011-4872-6_10.
Full textFenner, H. "New classification of aspirin-like drugs." In Selective COX-2 Inhibitors. Springer Netherlands, 1998. http://dx.doi.org/10.1007/978-94-011-4872-6_11.
Full textFord-Hutchinson, A. W. "New highly selective COX-2 inhibitors." In Selective COX-2 Inhibitors. Springer Netherlands, 1998. http://dx.doi.org/10.1007/978-94-011-4872-6_12.
Full textIsakson, P., B. Zweifel, J. Masferrer, et al. "Specific COX-2 inhibitors: from bench to bedside." In Selective COX-2 Inhibitors. Springer Netherlands, 1998. http://dx.doi.org/10.1007/978-94-011-4872-6_13.
Full textFurst, D. E. "Meloxicam: selective COX-2 inhibition in clinical practice." In Selective COX-2 Inhibitors. Springer Netherlands, 1998. http://dx.doi.org/10.1007/978-94-011-4872-6_14.
Full textConference papers on the topic "COX-2 selective inhibitor"
Powell, Daniel E. "Methodology for Designing Field Tests to Evaluate Different Types of Corrosion Inhibitors in Crude Oil Production Systems." In CORROSION 2004. NACE International, 2004. https://doi.org/10.5006/c2004-04367.
Full textHill, R. T., F. A. Ramirez, B. Monty, and G. Palanivel. "Material Selection Assessment for Topside Process Equipment for Production Fluids with High CO2 Content." In CORROSION 2011. NACE International, 2011. https://doi.org/10.5006/c2011-11118.
Full textSeiersten, Marion. "Corrosion of Mild Steel in Concentrated Monoethylene Glycol (MEG)." In CORROSION 2021. AMPP, 2021. https://doi.org/10.5006/c2021-16701.
Full textFartash, Roozbeh, Saba NavabZadeh, Habib Amirkhizi, and Mobin Salasi. "A Systematic Approach toward Selection of Cost-Effective and Corrosion Resistant Materials and Corrosion Inhibition and Protection Methods by Using Corrosion Prediction Models." In CORROSION 2010. NACE International, 2010. https://doi.org/10.5006/c2010-10368.
Full textLuft, H. B., K. E. Szklarz, J. Nowinka, and H. Skrzypek. "Evaluating Fitness-for-Purpose of Coiled Tubing for Underbalanced Drilling of Sour Wells." In CORROSION 2002. NACE International, 2002. https://doi.org/10.5006/c2002-02054.
Full textBarker, Richard, Michael Bryant, Frederick Pessu, and Anne Neville. "Determining the Behavior of Sulfur Compounds in Controlling Preferential Weld Corrosion in CO2-Saturated Brine." In CORROSION 2014. NACE International, 2014. https://doi.org/10.5006/c2014-4213.
Full textAmdekar, Sarika, and Vinod Singh. "Lactobacillus acidophilus A Selective COX 2 Inhibitor Protected Ovary and Testis in Induced Arthritic Model." In Annual International Conference on Advances in Biotechnology. Global Science & Technology Forum (GSTF), 2013. http://dx.doi.org/10.5176/2251-2489_biotech13.71.
Full textRao, Chinthalapally V., Suresh Guruswamy, Jagan Mohan R. Patlolla, Naveena Janakiram, and Venkat S. Malisetty. "Abstract A53: Chemoprevention of colon cancer by PBIT, an iNOS‐selective inhibitor, administered alone or in combination with low‐doses of celecoxib, a COX‐2 selective inhibitor." In Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Dec 6–9, 2009; Houston, TX. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1940-6207.prev-09-a53.
Full textTripathi, Shweta, Sudhir Chandna, B. S. Dwarkanath, Daman Saluja, and Madhu Chopra. "Abstract A37: Mechanistic study involving antiproliferative effect of Etoricoxib, a highly selective COX‐2 inhibitor on human cancer cell lines." In Abstracts: First AACR International Conference on Frontiers in Basic Cancer Research--Oct 8–11, 2009; Boston MA. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.fbcr09-a37.
Full textCurtis, SP, J. Maldonado-Cocco, BR Losada, et al. "FRI0030 Treatment with etoricoxib (mk-0663), a cox-2 selective inhibitor, resulted in maintenance of clinical improvement in rheumatoid arthritis." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.1159.
Full textReports on the topic "COX-2 selective inhibitor"
Splitter, Gary, Zeev Trainin, and Yacov Brenner. Lymphocyte Response to Genetically Engineered Bovine Leukemia Virus Proteins in Persistently Lymphocytic Cattle from Israel and the U.S. United States Department of Agriculture, 1995. http://dx.doi.org/10.32747/1995.7570556.bard.
Full textSadka, Avi, Mikeal L. Roose, and Yair Erner. Molecular Genetic Analysis of Citric Acid Accumulation in Citrus Fruit. United States Department of Agriculture, 2001. http://dx.doi.org/10.32747/2001.7573071.bard.
Full textOhad, Itzhak, and Himadri Pakrasi. Role of Cytochrome B559 in Photoinhibition. United States Department of Agriculture, 1995. http://dx.doi.org/10.32747/1995.7613031.bard.
Full text